全文获取类型
收费全文 | 3527篇 |
免费 | 248篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 93篇 |
妇产科学 | 230篇 |
基础医学 | 418篇 |
口腔科学 | 65篇 |
临床医学 | 452篇 |
内科学 | 526篇 |
皮肤病学 | 32篇 |
神经病学 | 515篇 |
特种医学 | 82篇 |
外科学 | 324篇 |
综合类 | 27篇 |
一般理论 | 2篇 |
预防医学 | 440篇 |
眼科学 | 43篇 |
药学 | 215篇 |
中国医学 | 2篇 |
肿瘤学 | 243篇 |
出版年
2023年 | 20篇 |
2022年 | 42篇 |
2021年 | 87篇 |
2020年 | 29篇 |
2019年 | 53篇 |
2018年 | 88篇 |
2017年 | 56篇 |
2016年 | 66篇 |
2015年 | 71篇 |
2014年 | 95篇 |
2013年 | 137篇 |
2012年 | 246篇 |
2011年 | 256篇 |
2010年 | 110篇 |
2009年 | 127篇 |
2008年 | 199篇 |
2007年 | 184篇 |
2006年 | 180篇 |
2005年 | 154篇 |
2004年 | 179篇 |
2003年 | 158篇 |
2002年 | 137篇 |
2001年 | 66篇 |
2000年 | 63篇 |
1999年 | 61篇 |
1998年 | 46篇 |
1997年 | 55篇 |
1996年 | 75篇 |
1995年 | 45篇 |
1994年 | 45篇 |
1993年 | 31篇 |
1992年 | 61篇 |
1991年 | 46篇 |
1990年 | 41篇 |
1989年 | 38篇 |
1988年 | 32篇 |
1987年 | 47篇 |
1986年 | 38篇 |
1985年 | 34篇 |
1984年 | 40篇 |
1983年 | 23篇 |
1982年 | 13篇 |
1981年 | 21篇 |
1980年 | 17篇 |
1979年 | 26篇 |
1978年 | 17篇 |
1977年 | 27篇 |
1976年 | 13篇 |
1975年 | 15篇 |
1974年 | 14篇 |
排序方式: 共有3786条查询结果,搜索用时 16 毫秒
991.
Head E Thornton PL Tong L Cotman CW 《Progress in neuro-psychopharmacology & biological psychiatry》2000,24(5):777-786
1. Normal aging is thought to proceed through two stages: initiation and propagation. Each of these phases is associated with different neuroanatomical events, vulnerabilities to injury and responsiveness to interventions. 2. The role of beta-amyloid (Abeta) in neuron dysfunction in the initiation stage may be mediated through alterations in signal transduction pathways involving cyclic AMP response element binding protein (CREB). CREB phosphorylation is associated with the expression of brain derived neurotrophic factor (BDNF), which promotes neuron health and survival. In primary neuronal cultures, Abeta decreases the phosphorylation of CREB, which results in up to a 31% decrease in BDNF levels. 3. In vivo studies also support a role for Abeta in neuron dysfunction since soluble Abeta levels correlate with the loss of synapses in brains of non-demented humans with high pathology. 4. The authors hypothesize that interventions during the initiation stage, when neuron dysfunction, but not overt pathology, is present, have the most promise to promote successful aging. The dog can serve as a useful model for interventions during the initiation stage since dogs develop neuropathology that closely resembles that observed in high pathology human brains. 相似文献
992.
Torp R Head E Cotman CW 《Progress in neuro-psychopharmacology & biological psychiatry》2000,24(5):801-810
1. An electron microscopic study was undertaken to study beta-amyloid (Abeta) deposition and neuropathology in aged dogs. 2. A positive correlation between Abeta deposits and neuropathology was found in some dogs. Massive Abeta deposition was correlated to advanced lesions. 3. By use of immunocytochemistry Abeta fibers were identified within plaques, around vessels and in association with cell membranes. 相似文献
993.
994.
Kovacs GG Head MW Bunn T Laszlo L Will RG Ironside JW 《Neuropathology and applied neurobiology》2000,26(5):463-472
The naturally occurring polymorphism at codon 129 of the human prion protein gene (PRNP) influences susceptibility to sporadic Creutzfeldt-Jakob Disease (CJD); the majority of the patients are methionine homozygotes at this locus, while valine homozygotes represent only 10% of cases. The aim was to study the clinical and neuropathological phenotype of sporadic CJD in valine homozygotes, to estimate the reliability of current clinical diagnostic criteria, and to identify any consistent and distinct features. Twelve cases of sporadic CJD with a codon 129 valine homozygote genotype were identified at the National CJD Surveillance Unit in Edinburgh. In addition to a retrospective clinical analysis, tissue blocks were stained by conventional techniques and by immunocytochemistry for prion protein. Frozen brain tissue was available from five cases for Western blot analysis of PrPRES, which in all cases showed a type 2 mobility. The cases included four males and eight females, average age 63.6 years, with a mean duration of illness of 6 months. Eleven patients presented with ataxia, and none had the characteristic EEG changes found in sporadic CJD. The neuropathological phenotype comprised spongiform change and prion protein immunopositivity most marked in the subcortical grey matter and cerebellum, prion protein positive plaque-like deposits in all regions, laminar deposition of prion protein in the cerebral cortex, and hippocampal involvement (which is seldom reported in sporadic CJD). In conclusion, these cases exhibited a fairly uniform phenotype, which is relatively distinct from sporadic CJD in methionine homozygotes, and thus diagnosis may be difficult using existing clinical criteria. 相似文献
995.
OBJECTIVE: To examine the use of low-dose ritonavir as a pharmacokinetic enhancer for HIV protease inhibitors. DATA SOURCES: Primary articles, review articles, and conference abstracts identified by MEDLINE search (1995-May 2001) and secondary sources. DATA SYNTHESIS: Low-dose ritonavir (100-200 mg) is increasingly being combined with HIV protease inhibitors to improve their effectiveness and allow less frequent dosing. An evaluation of the clinical evidence supporting this practice was conducted. CONCLUSIONS: Limited outcome data exist for low-dose ritonavir-based regimens in general. Although preliminary data appear promising, more clinical evidence is needed to determine the optimal dosing, long-term safety, and relative effectiveness of this approach. The role of these regimens in early therapy remains to be defined. 相似文献
996.
997.
998.
999.
Sandlund JT Harrison PL Rivera G Behm FG Head D Boyett J Rubnitz JE Gajjar A Raimondi S Ribeiro R Hudson M Relling M Evans W Pui CH 《Blood》2002,100(1):43-47
We determined the prognostic importance of morphologically identifiable persistent disease at day 15 and days 22 to 25 of remission induction in childhood acute lymphoblastic leukemia (ALL). Among 546 patients entered on 2 consecutive protocols, 397 patients had evaluable bone marrow (BM) examinations on day 15 (+/- 1 day) and 218 on days 22 to 25 (+/- 1 day). Fifty-seven patients (14%) had persistent lymphoblasts (> or = 1%) in the BM on day 15 and 27 patients (5.5%) had persistent lymphoblasts on days 22 to 25. The 5-year event-free survival (EFS) was significantly worse for patients with lymphoblasts on day 15 (40% +/- 6%) or on days 22 to 25 (4% +/- 3%) as compared to those without lymphoblasts on these dates (78% +/- 2% and 76% +/- 2%, respectively, P <.001 for both comparisons). A worse prognosis was observed even for patients with a low percentage of lymphoblasts (ie, 1%-4%) at either day 15 (5-year EFS = 56% +/- 8%) or days 22 to 25 (5-year EFS = 0%) compared to those without morphologically identifiable persistent lymphoblasts at these times (P <.001 for both comparisons). The prognostic impact of persistent lymphoblasts on both dates remained significant after adjusting for other known risk factors, including treatment protocol, age, white blood cell count, DNA index, cell lineage, and central nervous system status, and National Cancer Institute/Rome criteria simultaneously. Hence, persistence of lymphoblasts (even 1%-4%) on day 15 of remission induction was associated with a poor prognosis and on days 22 to 25 signified a particularly dismal outcome; these very high-risk patients require novel or more intensive therapy to improve outcome. 相似文献
1000.
List AF Kopecky KJ Willman CL Head DR Slovak ML Douer D Dakhil SR Appelbaum FR 《Blood》2002,100(5):1910-1912
Chronic myeloid leukemia blast phase (CML-BP) cells commonly express the multidrug transporter, P-glycoprotein (Pgp). To determine whether Pgp inhibition improves treatment outcome in CML-BP, the Southwest Oncology Group performed a randomized, controlled trial testing the benefit of the Pgp modulator, cyclosporin A (CsA). Seventy-three eligible patients were assigned to treatment with cytarabine and infusional daunorubicin with or without intravenous CsA. Treatment with CsA yielded no improvement in treatment outcome as measured by the frequency of induction resistance (68% vs 53%), rate of complete remission or restored chronic phase (CR/CP, 8% vs 30%), and survival (3 vs 5 months). Blast expression of Pgp (63%) and LRP (71%) was common, whereas only Pgp adversely impacted the rate of CR/CP (P =.025). We conclude that Pgp has prognostic relevance in CML-BP but that the modulation of Pgp function with CsA as applied in this trial is ineffective. 相似文献